Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients
ConclusionsOur data evidence that DPP-4 inhibition does not influence significantly GH/IGF-I system, confirming what was observed in animal models. Further studies are needed to better characterize the properties of these molecules on endocrine system.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Byetta | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Hormones | Janumet | Januvia | Metformin | Study